Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
25.00
0.01 (0.04%)
At close: Aug 15, 2025, 12:11 PM

Pacira BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
181.1M 168.92M 187.25M 168.57M 178.02M 167.12M 181.24M 163.93M 169.47M 160.34M 171.96M 167.47M 169.41M 157.99M 159.19M 127.72M 135.59M 119.03M
Cost of Revenue
40.87M 34.31M 39.89M 38.86M 58.58M 61.74M 62.01M 39.75M 48.21M 49.02M 61.92M 50.68M 50.63M 36.07M 39.01M 34.65M 35.25M 31.35M
Gross Profit
140.23M 134.62M 147.37M 129.71M 119.44M 105.38M 119.23M 124.18M 121.26M 111.32M 110.04M 116.79M 118.78M 121.92M 120.19M 93.07M 100.34M 87.68M
Operating Income
8.5M 1.99M 24.7M -139.53M 30.98M 15.12M 33.97M 17.72M 39.88M 12.15M 17.11M 11.51M 11.91M 17.39M 4.21M 31.43M 34.84M 19.44M
Interest Income
5.01M 6.89M 5.55M 5.48M 4.75M 3.9M 3.42M 2.77M 2.11M 3.14M 2.79M 1.23M 252K 271K 79K 177K 224K 415K
Pretax Income
-1.93M 8.71M 25.53M -138.86M 36.58M 13.64M 33.72M 16.6M 37.85M -26.47M -18.07M 2.07M 22.01M 7.29M -6.2M 24.23M 25.65M 12.72M
Net Income
-4.85M 4.81M 16.04M -143.47M 18.89M 8.98M 24.87M 10.86M 25.76M -19.54M -10.1M -693K 19.88M 6.83M -5.13M 17.66M 19.08M 10.37M
Selling & General & Admin
88.58M 86.78M 79.61M 74.33M 68.13M 72.03M 65.8M 67.95M 64.85M 70.84M 63.97M 61.28M 65M 64.26M 51.2M 48.81M 50.81M 48.52M
Research & Development
28.2M 25.34M 23.9M 19.1M 20.34M 18.24M 19.46M 20.83M 18.82M 17.14M 17.5M 19.41M 26.28M 21.61M 15.51M 11.58M 12.57M 15.88M
Other Expenses
14.96M 20.51M 19.15M 175.8M -39K -159K 515K -422K -269K 14.32M 14.32M 14.32M 14.32M 14.32M -65K -46K -2.4M -157K
Operating Expenses
131.73M 132.63M 122.66M 269.24M 88.46M 90.26M 85.26M 103.1M 98M 102.31M 95.8M 95.01M 105.61M 100.19M 75.32M 62.35M 65.35M 66.37M
Interest Expense
3.85M 4.58M 4.68M 4.69M 3.88M 3.32M 3.39M 3.46M 3.87M 9.59M 11.04M 9.86M 8.83M 10.25M 10.42M 7.33M 7.02M 6.97M
Selling & Marketing Expenses
50.96M 55.57M 50.34M 43.19M 39.05M 39.44M 35.74M 38.26M 37.46M 41.58M 36M 33.71M 36.85M 38.44M 29.36M 26.3M 28.26M 27.1M
Cost & Expenses
172.6M 166.93M 162.55M 308.1M 147.05M 152M 147.28M 142.85M 146.2M 151.32M 157.71M 145.69M 156.23M 136.26M 114.33M 97M 100.6M 97.72M
Income Tax Expense
2.92M 3.89M 9.48M 4.61M 17.7M 4.66M 8.85M 5.74M 12.09M -6.94M -7.97M 2.76M 2.13M 466K -1.07M 6.57M 6.57M 2.35M
Shares Outstanding (Basic)
45.46M 46.27M 46.17M 46.13M 46.17M 46.5M 46.44M 46.42M 46.09M 45.95M 45.88M 45.83M 49.87M 44.87M 44.59M 44.48M 44.15M 43.83M
Shares Outstanding (Diluted)
45.46M 46.53M 49.04M 46.13M 50.54M 52.19M 52.06M 52.07M 52.05M 45.95M 45.88M 45.83M 52.48M 46.44M 44.59M 45.46M 45.59M 45.97M
EPS (Basic)
-0.11 0.10 0.35 -3.11 0.41 0.19 0.54 0.23 0.56 -0.43 -0.22 -0.02 0.40 0.15 -0.12 0.40 0.43 0.24
EPS (Diluted)
-0.11 0.10 0.34 -3.11 0.39 0.19 0.48 0.23 0.49 -0.43 -0.22 -0.02 0.38 0.15 -0.12 0.39 0.42 0.23
EBITDA
29.24M 33.61M 51.45M -114.75M 49.84M 35.38M 52.45M 39.51M 42.32M 2.72M 23.38M 41.98M 34.04M 41.76M 60.94M 37.33M 37.54M 26.16M
EBIT
1.92M 12.44M 29.36M -135.01M 39.7M 16.27M 36.42M 19.38M 41.03M -16.89M -8.47M 11.02M 29.97M 16.36M 3.45M 31.56M 32.67M 19.04M
Depreciation & Amortization
27.32M 21.17M 21.24M 20.25M 18.86M 18.43M 18.48M 18.43M 19.05M 19.6M 30.41M 20.2M 20.86M 20.03M 13.07M 5.77M 4.87M 4.85M